When you or someone you love receives an osteosarcoma diagnosis, understanding the stage can feel like learning a new language during an overwhelming time. Staging describes how much the cancer has grown and whether it has spread, helping guide treatment decisions.
This guide explains what osteosarcoma stages mean, how doctors determine them, and where this bone cancer tends to spread. It also explores ways to support the body throughout the journey, including options for holistic treatment for bone cancer that complement conventional care.
What Staging Means for Osteosarcoma
Staging describes how much a cancer has grown or whether it has traveled to other parts of the body at diagnosis. Osteosarcoma accounts for approximately 5% of childhood tumors, and in children and adolescents, more than 50% of these tumors arise from the long bones around the knee.1
Doctors determine the stage by combining information from imaging scans, biopsy tissue samples, and physical examinations.
Why Osteosarcoma Staging Can Look Different Online
You may notice conflicting stage numbers online because two primary staging systems exist:
- The Musculoskeletal Tumor Society (MSTS/Enneking) system uses Stages I through III
- The American Joint Committee on Cancer (AJCC/TNM) system extends to Stage IV
In practice, the most meaningful distinction is often simpler: whether the osteosarcoma remains localized or has become metastatic.
For a broader context, you can explore our guide on how fast bone cancer spreads.
Key Factors Doctors Use to Stage Osteosarcoma
Three core elements determine an osteosarcoma’s stage: tumor grade, size, and local extent, and whether it has spread to distant sites. Medical teams evaluate all three together.
Tumor Grade
Grade describes how abnormal cancer cells look under a microscope compared to healthy bone tissue. Most osteosarcoma tumors are already high-grade when discovered, meaning the cells appear more abnormal and may grow more rapidly.
Tumor Size and Local Extent
Local extent refers to whether the tumor remains confined to the bone (intracompartmental) or has extended into surrounding soft tissues (extracompartmental). The AJCC system also uses 8 centimeters as a key size threshold.
This information helps surgical teams plan their approach, including determining what limb sparing surgery is and whether this procedure may be possible instead of amputation.
Metastasis Status
Metastasis means the cancer has spread beyond its original location. Whether spread has occurred is often the single most influential factor in determining both the stage and the treatment approach.
Osteosarcoma Stages
Both the MSTS and AJCC systems consider grade, local extent, and metastasis when assigning a stage for cancers that spread to bone.
Early/Localized Osteosarcoma
When osteosarcoma has not spread beyond its original bone, it is considered localized. About 4 out of 5 osteosarcomas appear to be localized when they are found.2
Stages I and II differ primarily by grade. Stage I tumors are low-grade, while Stage II tumors are high-grade but still confined to the primary site. Even when imaging suggests localized disease, microscopic cancer cells may have already spread, which is why chemotherapy is often part of the treatment plan. Outcomes vary significantly from person to person.
Metastatic Osteosarcoma (Often Referred to as Advanced/Stage 4)
When osteosarcoma has spread to distant locations, it is classified as metastatic. Under the MSTS system, this is Stage III, while the AJCC system designates it Stage IV, with IVA indicating lung-only spread and IVB indicating spread to other sites.
For people who have osteosarcoma that has spread when it is found, survival rates range from 5–30%.3 A metastatic diagnosis changes the treatment strategy, though care teams tailor their approach to each person’s unique situation.
Where Does Osteosarcoma Spread First?
Osteosarcoma most commonly spreads to the lungs before appearing in other distant locations.
Common First Site of Spread
This type of bone cancer travels through the bloodstream, and the lungs are its most frequent destination. The development of lung metastases is the single most important prognostic factor for osteosarcoma patients.4
Chest CT scans are standard during both initial evaluation and ongoing monitoring. Detecting lung involvement early can influence which treatment options remain available.
Other Possible Sites (Less Common)
Beyond the lungs, osteosarcoma may spread to other bones or, rarely, to the brain or other organs. For context on how different cancers spread to bone, explore cancers that do so.
Regular imaging confirms whether and where spread has occurred.
How Fast Does Osteosarcoma Spread?
Rather than a fixed timeline, the answer involves understanding individual risk factors and variability. Bone and joint cancer accounts for 0.2% of all new cancer cases in the U.S.5 This makes each case unique and underscores the importance of individualized assessment.
Every tumor behaves differently based on its unique biology. Two patients with identical staging may have very different experiences.
Doctors rely on imaging results, laboratory markers such as alkaline phosphatase and LDH, and treatment response rather than generalized timelines.
How Doctors Monitor Osteosarcoma for Spread Over Time
Once treatment begins, regular monitoring helps detect early changes.
Follow-up typically includes MRI of the original tumor site alongside chest CT scans. A bone scan or PET scan may supplement these in some cases. For help understanding these tools, see our comparison of PET vs bone scan.
Follow-up schedules are individualized based on stage, treatment response, and overall health.
Contact your care team quickly about:
- New or worsening bone pain
- Unexplained swelling
- Changes in mobility
- Persistent cough
- Any new unexplained symptoms
Early communication helps detect cancer coming back sooner.
Supportive and Integrative Care Alongside Medical Treatment
Many patients and families wonder what else they can do to support the body during this time, including exploring alternative treatment options as a primary treatment.
Supporting Strength, Recovery, and Well-Being
Nutrition, stress management, sleep quality, and mobility after bone surgery all contribute to overall wellness. Any treatment approach should be personalized.
Coordinating With Your Oncology Team
Open communication about your treatment choices helps ensure the best outcomes. Alternative care works most effectively when it serves as the foundation of your treatment plan.
Holistic Cancer Care at Immunity Therapy Center
Understanding osteosarcoma stages is an important step in navigating and coping with a diagnosis. For patients seeking personalized, non-invasive treatment that supports the immune system and whole-body wellness, Immunity Therapy Center offers a safer and effective treatment for cancer.
Founded in 2007 by Dr. Francisco Contreras Bautista, our Tijuana cancer center provides individualized care and welcomes patients from around the world, including those with advanced diagnoses. ITC’s programs incorporate holistic care principles, organic nutrition, and immunotherapy for cancer treatment designed to target cancer cells and support the body’s natural defenses.
Written By: Dr. Adolfo Carrillo
Dr. Adolfo Carrillo is a Board Certified Medical Doctor from Universidad Autónoma de Baja California.
Dr. Carrillo has been collaborating with Dr. Bautista for over 5 years as a treating physician at the Immunity the Immunity Therapy Center. Dr. Carrillo is a charismatic Doctor whose knowledge and commitment to patient care and bringing healing to patients is a valuable asset to our center.
Sources:
- National Cancer Institute (NCI). Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment (PDQ®)–Health Professional Version. https://www.cancer.gov/types/bone/hp/osteosarcoma-treatment-pdq
- American Cancer Society. Stages and Prognostic Markers of Osteosarcoma. https://www.cancer.org/cancer/types/osteosarcoma/detection-diagnosis-staging/staging.html
- American Cancer Society. Survival Rates for Osteosarcoma. https://www.cancer.org/cancer/types/osteosarcoma/detection-diagnosis-staging/survival-rates.html
- Nature (Communications Biology). The tumor microenvironment of metastatic osteosarcoma in the human and canine lung. https://www.nature.com/articles/s42003-025-07992-2
- SEER Program, National Cancer Institute (NCI). Cancer Stat Facts: Bone and Joint Cancer. https://seer.cancer.gov/statfacts/html/bones.html
